Low dose radiation therapy for COVID-19 pneumonia: brief review of the evidence

Horby P, Lim WS, Emerson J, Mafham M et al (2020) Effect of dexamethasone in hospitalised patients with COVID-19: prelininary report. MedRxiv. https://doi.org/10.1101/2020.06.22.20137273

Khan M et al (2020) Low-dose whole-lung radiation for COVID-19 pneumonia: planned day-7 interim analysis of an ongoing clinical trial. medRxiv https://doi.org/10.1101/2020.06.03.20116988

Kirkby C, Mackenzie M (2020) Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Oncol. https://doi.org/10.1016/j.radonc.2020.04.004

Doss M (2020) Treatment of COVID-19 pneumonia patients with X-rays. Phys Med Biol

Mortazavi SMJ, Kefayat A, Cai J (2020) Low dose radiation as a treatment for COVID-19 pneumonia: a threat or real opportunity. Med Phys. https://doi.org/10.1002/mp.14367

Calabrese E, Dhawan G (2013) How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med 86(4):555–570

Powell EV (1936) Radiation therapy of lobar pneumonia. Tex State J Med 32:237–240

Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034. https://doi.org/10.1016/S0140-6736(20)30630-9

Dhawan G, Kapoor R, Dhawan R, Singh R, Monga B, Giodarno J, Calabrese E (2020) Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiother Oncol. https://doi.org/10.1016/j.radonc.2020.05.002

Ott OJ, Micke O, Mücke R, Niewald M, Rodel F, Schafer U, Seegenschmiedt MH, Arenas M, Frey B, Gaipl US, German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) (2019) Low-dose radiotherapy mayday, mayday we’ve been hit! Strahlenther Onkol 195:285–288

Kefayat A, Ghahremani F (2020) Low dose radiation therapy for COVID-19 pneumonia: a double-edged sword. Radiother Oncol. https://doi.org/10.1016/j.radonc.2020.04.026

Trott KR, Zschaeck S, Beck M (2020) Radiation therapy for COVID-19 pneumopathy. Radiother Oncol 147:210–211. https://doi.org/10.1016/j.radonc.2020.05.003

Marks LB, Yorke E, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen S, Nam J, Deasy JO (2010) Use of normal tissue complication probability models in the clinic: QUANTEC. Int J Radiat Oncol Biol Phys 76(3):S10–S19

Preston DL, Ron E, Tokuoka S, Funomoto S, Nishi N, Soda M, Mabuchi K, Kodam K (2007) Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res 168:1–64

Whitaker M, Kron T, Sobolewski M, Dove R (2020) COVID-19 pandemic planning: considerations for radiation oncology medical physics. Phys Eng Sci Med. https://doi.org/10.1007/s13246-020-00869-0

Atun R, Jaffray D, Barton M, Bray F, Baumann M, Vikram B, Hanna T, Knaul F, Lievens Y, Lui T, Milosevic M, O’Sullivan B, Rodin D, Rosenblatt E, Van Dyk J, Zubizrreta E, Gospodarowicz M (2015) Expanding global access to radiotherapy. Lancet Oncol 16:1153–1186

Rahnama N, Ameri A (2020) Assessment of low dose pulmonary radiotherapy to the national protocol of COVID-19 management: a pilot study. Clinical trial web link NIH https://clinicaltrials.gov/ct2/show/record/NCT04390412